Search for Clinical Trial Results

Sponsored By

Lysosomal Acid Lipase Deficiency - 25 Studies Found

Status Study
No longer available Study Name: An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency
Condition: Lysosomal Acid Lipase Deficiency
Date: 2015-02-25
Interventions: Drug: sebelipase alfa Other Name: SBC-102, recombinant human lysosomal acid lipase, rhLAL
Active, not recruiting Study Name: Screening for Lysosomal Acid Lipase Deficiency
Condition: Lysosomal Acid Lipase Deficiency
Date: 2016-10-04
Interventions: Other: There is no intervention in the study
Active, not recruiting Study Name: Safety and Efficacy Study of Sebelipase Alfa in Patients With Lysosomal Acid Lipase Deficiency
Condition: Lysosomal Acid Lipase Deficiency
Date: 2014-03-20
Interventions: Drug: sebelipase alfa Intravenous infusion of sebelipase alfa: 1mg/kg every other week
Active, not recruiting Study Name: Clinical Trial in Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency
Condition: Lysosomal Acid Lipase Deficiency
Date: 2014-07-07
Interventions: Drug: sebelipase alfa Sebelipase alfa is a recombinant human lysosomal acid lipase (rhLAL). The investig
Completed Study Name: A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype
Condition:
  • Lysosomal Acid Lipase Deficiency
  • Wolman D
    Date: 2011-04-13
Terminated Study Name: Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102
Condition:
  • Lysosomal Acid Lipase Deficiency
  • Wolman D
    Date: 2011-11-10
    Interventions: Drug: SBC-102 SBC-102 is a recombinant human lysosomal acid lipase (rhLAL). The investigational medicina
Active, not recruiting Study Name: SurVival of Lysosomal Acid Lipase Deficiency (LAL-D) Infants Treated With SebelipAse aLfa
Condition:
  • Lysosomal Acid Lipase Deficiency
  • Wolman D
    Date: 2011-06-09
    Interventions: Drug: Sebelipase alfa (SBC-102) Sebelipase alfa is a recombinant human lysosomal acid lipase (rhLAL). Th
Active, not recruiting Study Name: Identification of Undiagnosed Lysosomal Acid Lipase Deficiency
Condition:
  • Lysosomal Acid Lipase Deficiency
  • Cholesterol Ester Storage Dise
    Date: 2012-10-26
    Interventions: Other: enzyme analysis
Active, not recruiting Study Name: A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
Condition:
  • Cholesterol Ester Storage Disease (CESD)
  • Lysosomal Acid Lipase Deficie
    Date: 2012-12-17
    Interventions:
    • Drug: SBC-102 [sebelipase alfa] (1 mg/kg)
Completed Study Name: Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Patients With Lysosomal Acid Lipase Deficiency
Condition:
  • Cholesterol Ester Storage Disease(CESD)
  • Lysosomal Acid Lipase Deficien
    Date: 2011-03-01
    Interventions:
    • Drug: SBC-102 (sebelipase alfa)

Next >>>